Jun-07 -

Gastro-Intestinal Group

EORTC 40953 – Randomized phase II study of weekly 24 h infusion of high dose 5-FU plus or minus Folinic Acid (HD-FU/FA) versus HD-FU/FA plus biweekly Cisplatin in advanced gastric cancer.

EORTC established the efficacy of the combined treatment of 5FU with cisplatin, in patients with advanced gastric cancer. This further contributed to the wealth of knowledge for treating advanced gastric cancer.


Go to Top